AXIOS November 15, 2025
Herb Scribner

A new once-a-day eye drop that can combat blurry vision is now commercially available in the United States.

Why it matters: These drops, previously approved by the Food and Drug Administration, could be a nonsurgical option for people who don’t want to seek out LASIK or other procedures.

Catch up quick: The FDA originally approved the VIZZ eyedrops in July, and the drugmaker LENZ Therapeutics expected to release samples of the product this fall.

  • Christian Pflaumer, a spokesperson for LENZ, told Axios in an email Thursday that the product is now available commercially in the U.S. after the company originally expected them to be available sometime before the end of the year.
  • The drops specifically combat presbyopia, a naturally...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Related Articles:
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 1)

Share Article